GlassScriptPhysician profile
Colby Shane Brownlee
NPI 1114289329
$1,757.21
in general payments reported to CMS, 2019-2025
17 companies · $365 in 2025
The $365 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.48 · 2020: $85.49 · 2021: $206 · 2022: $312 · 2023: $455 · 2024: $237 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.95 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $532.11 | 2022-2025 | Envista Envy Iol, Envista Mx60 Iol, Amvisc |
| Abbvie INC. | $300.12 | 2022-2025 | Durysta, Lumigan, Vuity |
| Glaukos Corporation | $209.85 | 2020-2024 | Idose, Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Nova Eye, INC. | $135.21 | 2021 | |
| Rxsight INC | $128.71 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Aerie Pharmaceuticals, INC. | $80.08 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $71.63 | 2021-2022 | |
| Allergan, INC. | $57.00 | 2021-2022 | |
| Astellas Pharma US INC | $56.19 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.07 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $29.15 | 2022 | |
| Merz Pharmaceuticals, LLC | $27.74 | 2023 | Xeomin |
| Sight Sciences, INC. | $24.75 | 2023 | Omni Surgical System |
| Alcon Vision LLC | $23.99 | 2023 | Rocklatan |
| Horizon Therapeutics Plc | $20.99 | 2023 | Tepezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $17.12 | 2022 | |
| New World Medical,INC. | $8.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colby Brownlee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.